Altya develops science-led health platforms designed to support biological function, resilience and healthy aging.
From Science to Scalable Health Platforms
Altya brings together specialist expertise and partners according to each project’s scientific, technical and commercial requirements. Throughout development, from research to industrial application, Altya maintains scientific direction, development oversight and intellectual property strategy.
01 Project requirements
We define the scientific objectives, intended application and technical and commercial requirements.
02 Relevant expertise
We assemble the research, formulation, clinical, regulatory and manufacturing expertise required for each project.
03 Integrated development
We coordinate specialist teams, evaluate findings and guide formulation and technical development.
04 Commercial application
We prepare the project for manufacturing, partnership and market introduction.
Built on Science. Designed for Translation.
Altya was established in Athens in 2024, building on a scientific foundation shaped by more than two decades of founder-led research, product development and international collaboration, beginning in 2003.
Michel Georges Magouritsas, Pharmacist, Ph.D., is Altya’s Founder and Chief Scientific Officer. He brings more than 30 years of pharmaceutical and nutraceutical R&D experience and has developed more than 400 products. This experience provides the scientific leadership and development expertise behind Altya’s Biological Optimization platforms.
Biological Optimization Platforms
Our three platforms address complementary areas of health: healthy aging and longevity, physiological support during GLP-1-based weight management, and cardiometabolic resilience.
01 Healthy Aging & Longevity
A hallmark-driven approach targeting biological mechanisms associated with aging, cellular resilience and long-term healthspan.
02 GLP-1 Companion Science
A physiological support platform designed around key biological challenges associated with GLP-1-based weight management.
03 Cardiometabolic Resilience
An integrated approach to biological mechanisms linking aging, metabolic health and cardiovascular resilience.
European Science. Italian Manufacturing Expertise. Global Reach.
Through established collaborations with specialized Italian manufacturing partners, Altya translates science-driven concepts into differentiated, market-ready products. By integrating formulation development, technical transfer, quality-led manufacturing and scalable production, we support pharmaceutical and healthcare partners across Food Supplements, Foods for Special Medical Purposes (FSMPs), Medical Devices and Cosmetics for international markets.
Partnering for the Next Generation of Health Innovation
Altya collaborates with pharmaceutical, healthcare and strategic partners to develop differentiated, science-driven solutions across its Biological Optimization platforms: Healthy Aging & Longevity, GLP-1 Companion Science and Cardiometabolic Resilience.
Partnership models range from platform licensing and co-development to strategic alliances and international commercialization.
